© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, West Pharmaceutical Services, Inc. (WST) shows an Average True Range (ATR) of 7.73 and an Enterprise Value of 27.69B. Its average trading volume over the past 3 months is 684.91K, indicating liquidity. These fundamental metrics provide insight into WST's underlying financial health and market activity.
West Pharmaceutical Services, Inc. (WST) technical indicators as of December 22, 2025: the SMA 20 is 0.54%, SMA 50 at 0.28%, and SMA 200 at 13.82%. The RSI 14 value is 52.95, suggesting its current momentum. These technical analysis signals help assess WST's price trends and potential future movements.
West Pharmaceutical Services, Inc. (WST) stock performance overview as of December 22, 2025: The 52-week high is $348.9 (currently -21.21% below), and the 52-week low is $187.43 (currently 46.66% above). Over the past year, WST's performance is -16.84%, compared to the S&P 500's 12.87% change.
According to market data, West Pharmaceutical Services, Inc. (WST) stock's recent performance metrics show that over the last month, WST is 6.59%, with a Year-to-Date (YTD) performance of -16.08%. Over the past year, the stock has seen a -16.84% change. These figures summarize WST's price movements across various periods, reflecting its historical returns.
According to current financial data, WST stock's P/E (TTM) ratio is 40.52, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for WST, including P/S (6.57), P/B (6.53), and P/FCF (52.30), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.